Newly published data recently revealed just how common the extent of prostate cancer is underestimated based on imaging measurements. 

The findings support adopting F-18 DCFPyL PET/CT as the standard of care for prostate cancer staging, authors of a new Scientific Reports paper concluded.

Difficulty obtaining PET/CT scans was reported by 55% of respondents, with 21% citing this as the greatest barrier in treating classic Hodgkin lymphoma.

That’s according to an award-winning scientific online poster presented this week during the American Roentgen Ray Society’s annual meeting being held in Honolulu, Hawaii.

Features pertaining to location, density and superimposed structures were recently found to be associated with poorer outcomes for patients who initially had their lung cancer overlooked on radiographs.

The AUC includes a total of 32 clinical scenarios that have been grouped into four categories of cancer: breast, skin, cancer of other sites and lymphedema.

Coming in at a diameter of 5 mm and thickness of 0.2 mm, the X-ray dosimeter measures radiation dose up to five times more accurately than standard methods. 

Cases of mistaken malignancy have become more common as the popularity of tattoos has grown in recent years.